Search Results - "Tosca, Mónica"

Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma by Aya, Francisco, Gaba, Lydia, Victoria, Iván, Fernández-Martínez, Aranzazu, Tosca, Mónica, Prat, Aleix, Arance, Ana

“…While both efficacy and safety of anti-PD-1 agents seem to be independent of previous treatment with anti-CTLA-4, limited data exist of efficacy and toxicity…”
Get full text

Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab by Aya, Francisco, Fernández-Martínez, Aranzazu, Gaba, Lydia, Victoria, Iván, Tosca, Mónica, Carrera, Cristina, Prat, Aleix, Arance, Ana

“…Currently, limited data exist on the safety of pembrolizumab in patients with metastatic melanoma who have developed severe immune-related adverse events…”
Get full text

Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer by Gallego, Rosa, Codony-Servat, Jordi, García-Albéniz, Xabier, Carcereny, Enric, Longarón, Raquel, Oliveras, Angeles, Tosca, Mónica, Augé, Josep Maria, Gascón, Pedro, Maurel, Joan

“…Insulin-like growth factor-I (IGF-I) is thought to have antiapoptotic and mitogenic properties in colorectal cancer, whereas IGF-binding protein-3 (IGFBP-3)…”
Get full text

Pembrolizumab in a by Aya, Francisco, Fernández-Martínez, Aranzazu, Gaba, Lydia, Victoria, Iván, Tosca, Mónica, Carrera, Cristina, Prat, Aleix, Arance, Ana

“…Currently, limited data exist on the safety of pembrolizumab in patients with metastatic melanoma who have developed severe immune-related adverse events…”
Get full text

Life-threatening colitis and complete response with ipilimumab in a patient with metastatic BRAF-mutant melanoma and rheumatoid arthritis by Aya, Francisco, Gaba, Lydia, Victoria, Ivan, Fernandez-Martinez, Aranzazu, Ruiz-Esquide, Virginia, Pineda, Estela, Tosca, Monica, Viladot, Margarita, Pereira, Veronica, Malvehy, Josep, Prat, Aleix, Arance, Ana

“…Immune checkpoint inhibitors, such as ipilimumab (an anti-CTLA4 antibody), have become a commonly used therapy in cancer. To date, safety data of patients with…”
Get full text

Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients by Ugidos, Lisardo, Delgado, Salvadora, Conill, Carlos, Ginés, Angels, Gallego, Rosa, Ayuso, Juan Ramón, Miquel, Rosa, Tosca, Monica, de Lacy, Antonio, Castells, Antoni, Maurel, Joan

“…Summary Background : To analyze the feasibility of capecitabine with weekly irinotecan and concurrent radiotherapy followed by laparoscopic-total mesorectal…”
Get full text